JHOP - June 2017 Vol 7, No 2

Prostate cancer is the second leading cause of cancer-related mortality, and accounts for 10% of cancer-related deaths in American men. It is estimated that 1 in 9 men will have prostate cancer during their lifetime, and an estimated 161,363 new cases and 26,730 prostate cancer–related deaths are expected in the United States in 2017.
Healthcare has become increasingly costly with the advent of advanced technologies, and the field of oncology has not been spared from issues related to cost.
Pharmacists are becoming increasingly involved in cancer care. This raises a vital question: How aware are pharmacy students of the expanding roles and opportunities in oncology pharmacy?
This section provides a quick update of symptomatic conditions in oncology and their management. Readers are invited to submit brief updates following the guidelines at www.JHOPonline.com.
The paradigm of oncology practice has changed significantly in recent years with the rapid emergence and use of oral chemotherapy agents.

Results 1 - 5 of 5